Maktaba

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Patient-reported pain and physical health for acupuncture and chiropractic care delivered by Veterans Affairs versus community providers.

Authors : O'Hanlon CE; Veterans Affairs Greater Los Angeles Healthcare System, Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), Los Angeles, California, United States of America.; RAND Corporation, Santa Monica, California, United States of America.

Subjects: United States Department of Veterans Affairs* ; Acupuncture Therapy* ; Manipulation, Chiropractic*/Manipulation, Chiropractic*/Manipulation, Chiropractic*/statistics & numerical data

Source: PloS one [PLoS One] 2024 May 15; Vol. 19 (5), pp. e0303651. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

Authors : Li Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.; Wang X

Subjects: Dibenzothiepins*/Dibenzothiepins*/Dibenzothiepins*/adverse effects ; Triazines*/Triazines*/Triazines*/adverse effects ; Oseltamivir*/Oseltamivir*/Oseltamivir*/adverse effects

Source: BMC infectious diseases [BMC Infect Dis] 2024 May 09; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 May 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list

Academic Journal

FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States.

Authors : Paniz-Mondolfi AE; Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Ramírez JD

Subjects: Neglected Diseases*/Neglected Diseases*/Neglected Diseases*/epidemiology ; United States Food and Drug Administration*/United States Food and Drug Administration*/United States Food and Drug Administration*/legislation & jurisprudence ; Communicable Diseases, Emerging*/Communicable Diseases, Emerging*/Communicable Diseases, Emerging*/epidemiology

Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 May 09; Vol. 18 (5), pp. e0012116. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list

Academic Journal

Clarification of Information in "Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance Tests".

Authors : Lockwood CM; Department of Laboratory Medicine and Pathology, University of Washington Medicine, Seattle.

Subjects: United States Food and Drug Administration* ; High-Throughput Nucleotide Sequencing* ; Laboratory Proficiency Testing*

Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 May 01; Vol. 148 (5), pp. 507.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print

Record details

Read Online Read More Add to Saved list

Academic Journal

Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system.

Authors : Zhang X; Department of Pharmacy, Suining Central Hospital, No.127, West Desheng Road, Chuanshan District, Suining, 629000, Sichuan, People's Republic of China.; Xia L

Subjects: United States Food and Drug Administration* ; Hearing Loss*/Hearing Loss*/Hearing Loss*/chemically induced ; Hearing Loss*/Hearing Loss*/Hearing Loss*/epidemiology

Source: Scientific reports [Sci Rep] 2024 Apr 28; Vol. 14 (1), pp. 9743. Date of Electronic Publication: 2024 Apr 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Perspectives on supporting Veterans' social needs during hospital to home health transitions: findings from the Transitions Nurse Program.

Authors : Daus M; Denver/Seattle Center of Innovation for Veteran-Centered and Value Driven Care, VHA Eastern Colorado Healthcare System, 1700 N Wheeling St, Aurora, CO, 80045, USA. .; Lee M

Subjects: Home Care Services*/Home Care Services*/Home Care Services*/organization & administration ; Veterans*/Veterans*/Veterans*/psychology ; Qualitative Research*

Source: BMC health services research [BMC Health Serv Res] 2024 Apr 25; Vol. 24 (1), pp. 520. Date of Electronic Publication: 2024 Apr 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

Record details

Read Online Read More Add to Saved list

Academic Journal

An empirical analysis of overall survival in drug approvals by the US FDA (2006-2023).

Authors : Elbaz J; Hofstra University, Hempstead, New York, USA.; Haslam A

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/statistics & numerical data ; United States Food and Drug Administration* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7190.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited

Record details

Read Online Read More Add to Saved list

Periodical

'Damning' FDA inspection report undermines Alzheimer's drug.

Authors : Piller C

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Scientific Misconduct* ; Spiro Compounds*/Spiro Compounds*/Spiro Compounds*/therapeutic use

Source: Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1165-1166. Date of Electronic Publication: 2024 Mar 14.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

First Decade of Supportive Services for Veteran Families Program and Homelessness, 2012-2022.

Authors : Wilkinson R; Renae Wilkinson, Richard G. Cowden, and Katelyn N. G. Long are with the Human Flourishing Program, Institute for Quantitative Social Science, Harvard University, Cambridge, MA. Thomas Byrne is with the School of Social Work, Boston University, Boston, MA. John H. Kuhn is with the VA Greater Los Angeles Healthcare System, Los Angeles, CA. Howard K. Koh is with the Harvard T. H. Chan School of Public Health, Boston, MA. Jack Tsai is with the US Department of Veterans Affairs, National Center on Homelessness Among Veterans, Washington DC.; Byrne T

Subjects: Ill-Housed Persons* ; United States Department of Veterans Affairs*/United States Department of Veterans Affairs*/United States Department of Veterans Affairs*/organization & administration ; Veterans*

Source: American journal of public health [Am J Public Health] 2024 Jun; Vol. 114 (6), pp. 610-618.Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074 Publication Model: Print

Record details

Read Online Read More Add to Saved list

Periodical

EPA scraps plan to end all testing in mammals by 2035.

Authors : Grimm D

Subjects: United States Environmental Protection Agency* ; Animal Experimentation* ; Toxicity Tests*

Source: Science (New York, N.Y.) [Science] 2024 Jan 19; Vol. 383 (6680), pp. 248. Date of Electronic Publication: 2024 Jan 18.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Patient-reported pain and physical health for acupuncture and chiropractic care delivered by Veterans Affairs versus community providers.

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States.

Clarification of Information in "Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance Tests".

Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system.

Perspectives on supporting Veterans' social needs during hospital to home health transitions: findings from the Transitions Nurse Program.

An empirical analysis of overall survival in drug approvals by the US FDA (2006-2023).

'Damning' FDA inspection report undermines Alzheimer's drug.

First Decade of Supportive Services for Veteran Families Program and Homelessness, 2012-2022.

EPA scraps plan to end all testing in mammals by 2035.